Background/Aims: Children with cystic fibrosis (CF) are of increased risk of reduced fat body mass (FBM) and lean body mass (LBM). Serum concentrations of insulin-like growth factor-1 (IGF-1)and leptin could be markers of LBM and/or FBM depletion. To evaluate the relationships between disease activity, body composition, IGF-1and leptin concentrations in CF children. Methods: A cross-sectional study with 26 CF children aged 5.0–15.5 years and 33 healthy controls, mean age 9.4 years. Body composition was evaluated by dual-energy X-ray absorptiometry. Fasting blood samples were analyzed for leptin, IGF-1and IGFBP-3. Results: FBM standard deviation score (SDS; CF boys –0.02 ± 0.88 vs. 0.78 ± 0.65, p < 0.01; CF girls –0.37 ± 1.15 vs. 0.70 ± 0.97, p < 0.05), leptin concentration (CF boys 2.07 ± 0.79 vs. 3.07 ± 1.28 ng/ml, p < 0.05; CF girls 2.71 ± 0.86 vs. 5.00 ± 2.95 ng/ml, p < 0.05) and IGF-1SDS (CF boys –1.43 ± 1.50 vs. –0.32 ± 0.88, p < 0.05; CF girls –0.66 ± 1.66 vs. 0.64 ± 0.57, p < 0.01) were lower in CF children compared to controls. Shwachman score was the strongest predictor of lean body mass (R = 0.63). Leptin levels explain 60% of the variability in FBM. Conclusion: Serum concentrations of IGF-1 and leptin are decreased in children with CF and are associated with clinical conditions and body composition.

Keywords:
Cystic fibrosis, Body composition, Insulin-like growth factor-1, Leptin, Growth retardation
1.
Wilmott RW, Fiedler MA: Recent advances in the treatment of cystic fibrosis. Pediatr Clin N Am 1994;41:431–451.
2.
Doull IJM: Recent advances in cystic fibrosis. Arch Dis Child 2001;85:62–66.
3.
Cystic Fibrosis Foundation: Cystic fibrosis foundation patient registry annual data report. Cystic Fibrosis Foundation, 2000.
4.
Ionescu AA, Nixon LS, Evans WD, Stone MD, Lewis-Jenkins V, Chatham K, Shale DJ: Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000;162:789–794.
5.
Ionescu AA, Chatham K, Davies CA, Nixon LS, Enright S, Shale DJ: Inspiratory muscle function and body composition in cystic fibrosis. Am J Respir Crit Care Med 1998;158:1271–1276.
6.
Pinet C, Cassart M, Scillia P, Lamotte M, Knoop C, Casimir G, Mélot C, Estenne M: Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir Crit Care Med 2003;168:989–994.
7.
Taylor AM, Bush A, Thomson A, Oades PJ, Marchant JL, Bruce-Morgan C, Holly J, Ahmed L, Dunger DB: Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis. Arch Dis Child 1997;76:304–309.
8.
Sermet-Gaudelus I, Souberbielle JC, Azhar I, Ruiz JC, Magnine P, Colomb V, Le Bihan C, Folio D, Lenoir G: Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients. Arch Dis Child 2003;88:956–961.
9.
Laursen EM, Juul A, Lanng S, Hoiby N, Koch C, Muller J, Skakkebaek NE: Diminished concentrations of insulin-like growth factor I in cystic fibrosis. Arch Dis Child 1995;72:494–497.
10.
Takabatake N, Nakamura H, Abe S, Hino T, Saito H, Yuki H, Kato S, Tomoike H: Circulating leptin in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159:1215–1219.
11.
Arumugam R, LeBlanc A, Seilheimer DK, Hardin DS: Serum leptin and IGF-1levels in cystic fibrosis. Endocr Res 1998;24:247–257.
12.
Ahmed ML, Ong KK, Thomson AH, Dunger DB: Reduced gains in fat and fat-free mass, and elevated leptin levels in children and adolescents with cystic fibrosis. Acta Paediatr 2004;93:1185–1191.
13.
La Cava A, Matarese G: The weight of leptin in immunity. Nat Rev Immunol 2004;4:371–379.
14.
Shwachman H, Kulczycky LL: Studies made over a five to fourteen year period of 105 patients with cystic fibrosis. Am J Dis Child 1958;96:6–15.
15.
Borowitz D, Baker RD, Stallings V: Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35:246–259.
16.
Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.
17.
Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R, Mei Z, Curtin LR, Roche AF, Johnson CL: CDC growth charts: United States. Adv Data 2000;314:1–27.
18.
van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM: Reference data for bone density and body composition measured with dual energy X-ray absorptiometry in white children and young adults. Arch Dis Child 2002;87:341–347.
19.
Lofqvist C, Andersson E, Gelander L, Rosberg S, Blum WF, Albertsson Wikland K: Reference values for IGF-1throughout childhood and adolescence: a model that accounts simultaneously for the effect of gender, age, and puberty. J Clin Endocrinol Metab 2001;86:5870–5876.
20.
Lofqvist C, Andersson E, Gelander L, Rosberg S, Hulthen L, Blum WF, Wikland KA: Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 2005;90:1420–1427.
21.
Lai HC, Corey M, FitzSimmons S, Kosorok MR, Farrell PM: Comparison of growth status of patients with cystic fibrosis between the United States and Canada. Am J Clin Nutr 1999;69:531–538.
22.
Stettler N, Kawchak DA, Boyle LL, Propert KJ, Scanlin TF, Stallings VA, Zemel BS: Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis. Am J Clin Nutr 2000;72:407–413.
23.
McNaughton SA, Shepherd RW, Greer RG, Cleghorn GJ, Thomas BJ: Nutritional status of children with cystic fibrosis measured by total body potassium as a marker of body cell mass: lack of sensitivity of anthropometric measures. J Pediatr 2000;136:188–194.
24.
Steinkamp G, Wiedemann B: Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project. Thorax 2002;57:596–601.
25.
Street ME, Ziveri MA, Spaggiari C, Viani I, Volta C, Grzincich GL, Virdis R, Bernasconi S: Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis. Eur J Endocrinol 2006;154:47–52.
26.
Fors H, Gelander L, Bjarnason R, Albertsson-Wikland K, Bosaeus I: Body composition, as assessed by bioelectrical impedance spectroscopy and dual-energy X-ray absorptiometry, in a healthy paediatric population. Acta Paediatr 2002;91:755–760.
27.
Boot AM, Bouquet J, de Ridder MA, Krenning EP, de Muinck Keizer-Schrama SM: Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr 1997;66:232–238.
28.
Franca Junior I, da Silva GR, Monteiro CA: Secular trends of height in adulthood of children born in the city of Sao Paulo, Brazil from 1950–1976. Rev Saude Publ 2000;34(6 suppl):102–107.
29.
Hintz RL, Susking R, Amatavakul K, Thanangkul O, Olson R: Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition. J Pediat 1978;92:153–156.
30.
Counts DR, Gwirtsman H, Carlsson LM, Lesem M, Cutler GB Jr: The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 1992;75:762–767.
31.
Ripa P, Robertson I, Cowley D, Harris M, Masters B, Cotterill AM: The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis. Clin Endocrinol 2002;56:383–389.
32.
Thissen JP, Ketelslegers JM, Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80–101.
33.
Garnett SP, Hogler W, Blades B, Baur LA, Peat J, Lee J, Cowell CT: Relation between hormones and body composition, including bone, in prepubertal children. Am J Clin Nutr 2004;80:966–972.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.